Earlier, The Lancet published results of Phase Three clinical trials of the Russian vaccine according to which it is one of the safest and the most effective worldwide
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
14 Jan in 22:00
The Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry plans to begin clinical trials of a combined vaccine against the coronavirus and flu in the middle of 2022, Center’s Director Alexander Gintsburg said, TASS reports. [Clinical trials] are in the work schedule. We are doing this, we created a technology which allows to hope that it will be possible to create such a vaccine. . We are planning to begin clinical trials by the middle, the second half of next year. If before this we conduct everything on animals and will see that it is promising, he said.